Evidence map›Paper›PMID 39420407›Full record

ArticleInternational journal of retina and vitreous2024

Applications of ChatGPT in the diagnosis, management, education, and research of retinal diseases: a scoping review.

Victor C F Bellanda, Mateus Lins Dos Santos, Daniel Araujo Ferraz, Rodrigo Jorge, Gustavo Barreto Melo

Abstract readScoping Review
In one paragraph

Article in International journal of retina and vitreous, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Recent Advances in AI and GenAI for Health Informatics.Healthcare (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Victor C F BellandaRibeirão Preto Medical School, University of São Paulo, 3900 Bandeirantes Ave, Ribeirão Preto, SP, 14049-900, Brazil. victorfbellanda@gmail.com.
Mateus Lins Dos SantosSergipe Eye Hospital, Aracaju, SE, Brazil.
Daniel Araujo FerrazD'Or Institute for Research & Education, Rio de Janeiro, RJ, Brazil.
Rodrigo JorgeRibeirão Preto Medical School, University of São Paulo, 3900 Bandeirantes Ave, Ribeirão Preto, SP, 14049-900, Brazil.
Gustavo Barreto MeloSergipe Eye Hospital, Aracaju, SE, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis scoping review aims to explore the current applications of ChatGPT in the retina field, highlighting its potential, challenges, and limitations.

methodsA comprehensive literature search was conducted across multiple databases, including PubMed, Scopus, MEDLINE, and Embase, to identify relevant articles published from 2022 onwards. The inclusion criteria focused on studies evaluating the use of ChatGPT in retinal healthcare. Data were extracted and synthesized to map the scope of ChatGPT's applications in retinal care, categorizing articles into various practical application areas such as academic research, charting, coding, diagnosis, disease management, and patient counseling.

resultsA total of 68 articles were included in the review, distributed across several categories: 8 related to academics and research, 5 to charting, 1 to coding and billing, 44 to diagnosis, 49 to disease management, 2 to literature consulting, 23 to medical education, and 33 to patient counseling. Many articles were classified into multiple categories due to overlapping topics. The findings indicate that while ChatGPT shows significant promise in areas such as medical education and diagnostic support, concerns regarding accuracy, reliability, and the potential for misinformation remain prevalent.

conclusionChatGPT offers substantial potential in advancing retinal healthcare by supporting clinical decision-making, enhancing patient education, and automating administrative tasks. However, its current limitations, particularly in clinical accuracy and the risk of generating misinformation, necessitate cautious integration into practice, with continuous oversight from healthcare professionals. Future developments should focus on improving accuracy, incorporating up-to-date medical guidelines, and minimizing the risks associated with AI-driven healthcare tools.

Indexed as

Artificial intelligenceAutomationDecision support systems, clinicalEducation, medicalEducation, patientHealth information systemsOphthalmologyRetinal diseases

Identifiers

PMID39420407
PMCPMC11487877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.